DE3888205T2 - Verfahren zur behandlung von lungenaffektionen und zubereitungen dafür. - Google Patents

Verfahren zur behandlung von lungenaffektionen und zubereitungen dafür.

Info

Publication number
DE3888205T2
DE3888205T2 DE3888205T DE3888205T DE3888205T2 DE 3888205 T2 DE3888205 T2 DE 3888205T2 DE 3888205 T DE3888205 T DE 3888205T DE 3888205 T DE3888205 T DE 3888205T DE 3888205 T2 DE3888205 T2 DE 3888205T2
Authority
DE
Germany
Prior art keywords
treating lung
preparations therefor
affects
lung affects
therefor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3888205T
Other languages
English (en)
Other versions
DE3888205D1 (de
Inventor
Arthur Ammann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DE3888205D1 publication Critical patent/DE3888205D1/de
Application granted granted Critical
Publication of DE3888205T2 publication Critical patent/DE3888205T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
DE3888205T 1987-08-07 1988-07-29 Verfahren zur behandlung von lungenaffektionen und zubereitungen dafür. Expired - Lifetime DE3888205T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/083,605 US4944941A (en) 1987-08-07 1987-08-07 Methods and compositions for the treatment of lung conditions
PCT/US1988/002609 WO1989001341A1 (en) 1987-08-07 1988-07-29 Methods and compositions for the treatment of lung conditions

Publications (2)

Publication Number Publication Date
DE3888205D1 DE3888205D1 (de) 1994-04-07
DE3888205T2 true DE3888205T2 (de) 1994-08-11

Family

ID=22179461

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3888205T Expired - Lifetime DE3888205T2 (de) 1987-08-07 1988-07-29 Verfahren zur behandlung von lungenaffektionen und zubereitungen dafür.

Country Status (8)

Country Link
US (1) US4944941A (de)
EP (1) EP0395639B1 (de)
JP (1) JP2765585B2 (de)
AU (1) AU2260088A (de)
CA (1) CA1335175C (de)
DE (1) DE3888205T2 (de)
NZ (1) NZ225675A (de)
WO (1) WO1989001341A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925375A (en) * 1987-05-22 1999-07-20 The Liposome Company, Inc. Therapeutic use of multilamellar liposomal prostaglandin formulations
IT1248838B (it) * 1990-06-13 1995-01-30 Sclavo Spa Soluzioni tampone contenenti collagenasi, loro preparazione ed uso perla diluizione di sieri umani
US5990096A (en) * 1990-09-18 1999-11-23 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5910489A (en) * 1990-09-18 1999-06-08 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5824658A (en) * 1990-09-18 1998-10-20 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
CA2061703C (en) * 1992-02-20 2002-07-02 Rudolf E. Falk Formulations containing hyaluronic acid
US5204094A (en) * 1991-01-17 1993-04-20 Roussel Uclaf Treatment of pneumothorax
US5977088A (en) * 1991-07-03 1999-11-02 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US6103704A (en) * 1991-07-03 2000-08-15 Hyal Pharmaceutical Corporation Therapeutic methods using hyaluronic acid
US5792753A (en) * 1991-07-03 1998-08-11 Hyal Pharmaceutical Corporation Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
US5342612A (en) * 1991-12-20 1994-08-30 American Cyanamid Company Compositions for the treatment of mammalian diseases
US5266312A (en) * 1992-01-07 1993-11-30 National Jewis Center For Immunology And Respiratory Medicine Method for treating a steroid resistant condition via administration of gamma interferon
US6218373B1 (en) 1992-02-20 2001-04-17 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5767106A (en) * 1992-02-21 1998-06-16 Hyal Pharmaceutical Corporation Treatment of disease and conditions associated with macrophage infiltration
US5248504A (en) * 1992-03-02 1993-09-28 Friedman William H Method of treatment for nasal and sinus dysfunction
US5582825A (en) * 1993-02-24 1996-12-10 Gunze Limited Therapeutic medicine for cystic fibrosis
US5840277A (en) * 1993-03-30 1998-11-24 Charlotte Hospital Authority Treatment of chronic pulmonary inflammation
CA2102142A1 (en) * 1993-03-30 1994-10-01 Andrew J. Ghio Method of inhibiting oxidants using alkylaryl polyether alcohol polymers
US5830436A (en) * 1993-03-30 1998-11-03 Duke University Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers
US5849263A (en) * 1993-03-30 1998-12-15 Charlotte-Mecklenburg Hospital Authority Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
US5451569A (en) * 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
DE4434629C1 (de) * 1994-09-28 1996-06-27 Byk Gulden Lomberg Chem Fab Zusammensetzungen zur Behandlung von IRDS und ARDS
US5674483A (en) * 1995-01-31 1997-10-07 National Jewish Medical And Research Center Treatment for diseases involving inflammation
EP1759708A1 (de) * 1995-07-25 2007-03-07 Toray Industries, Inc. IFN-beta zur Behandlung von krebs-verwandten Knochenerkrankungen
EP0795332B1 (de) * 1996-03-14 2005-06-01 Mondobiotech Interferon SA Medizinische Verwendung von Gamma-Interferon im interstitiellen Lungenerkrankungen
ES2314786T3 (es) 1998-04-02 2009-03-16 Genentech, Inc. Uso de interferon gamma para el tratamiento de la hipertrofia cardiaca.
US6858223B2 (en) * 1998-06-23 2005-02-22 Altana Pharma Ag Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ARDS) and infant respiratory distress syndrome (IRDS)
CA2390292A1 (en) 1999-11-12 2001-05-25 Maxygen Holdings Ltd. Interferon gamma conjugates
CN1309423C (zh) 1999-11-12 2007-04-11 马克西根控股公司 干扰素γ偶联物
EP1351707B9 (de) * 2001-01-09 2012-01-25 Baylor Research Institute Verfahren zur behandlung von autoimmunerkrankungen bei einem probanden und diagnostische in-vitro-assays
US7038015B2 (en) * 2001-04-06 2006-05-02 Maxygen Holdings, Ltd. Interferon gamma polypeptide variants
US6958388B2 (en) 2001-04-06 2005-10-25 Maxygen, Aps Interferon gamma polypeptide variants
AU2003239774A1 (en) * 2002-07-03 2004-01-23 Maxygen Holdings Ltd. Full-length interferon gamma polypeptide variants
WO2006013183A1 (en) * 2004-08-06 2006-02-09 Altana Pharma Ag Composition comprising a pulmonary surfactant and a tnf-derived peptide
WO2006093153A1 (ja) * 2005-02-28 2006-09-08 Cellseed Inc. 培養細胞シート、製造方法及びその利用した組織修復方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
US4522811A (en) * 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
JPS60228422A (ja) * 1984-04-26 1985-11-13 Suntory Ltd 安定化された生理活性物質製剤
US4650674A (en) * 1984-07-05 1987-03-17 Genentech, Inc. Synergistic cytotoxic composition
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
CA1260393A (en) * 1984-10-16 1989-09-26 Lajos Tarcsay Liposomes of synthetic lipids
US4774085A (en) * 1985-07-09 1988-09-27 501 Board of Regents, Univ. of Texas Pharmaceutical administration systems containing a mixture of immunomodulators
EP0257956B2 (de) * 1986-08-19 2000-11-22 Genentech, Inc. Verwendung von Polypeptidwuchsstoffen und Zytokinen zur Herstellung eines Geräts und einer Dispersion
DE3784650D1 (de) * 1986-12-12 1993-04-15 Ciba Geigy Ag Vorbeugende massnahmen zur verhinderung der "komplexen respiratorischen erkrankung bei rindern" durch verabreichung von interferon.

Also Published As

Publication number Publication date
EP0395639B1 (de) 1994-03-02
DE3888205D1 (de) 1994-04-07
AU2260088A (en) 1989-03-09
US4944941A (en) 1990-07-31
EP0395639A1 (de) 1990-11-07
JP2765585B2 (ja) 1998-06-18
NZ225675A (en) 1991-02-26
WO1989001341A1 (en) 1989-02-23
CA1335175C (en) 1995-04-11
JPH03500768A (ja) 1991-02-21

Similar Documents

Publication Publication Date Title
DE3888205D1 (de) Verfahren zur behandlung von lungenaffektionen und zubereitungen dafür.
DE3485688D1 (de) Verfahren und vorrichtung zur behandlung von krankheiten.
DE3877834D1 (de) Verfahren zur behandlung von abgasen.
DE3869490D1 (de) Verfahren zur elektrochemischen behandlung von stoffen.
DE3583942D1 (de) Verfahren zur behandlung von fluiden.
DE69010893T2 (de) Verfahren zur behandlung von koks sowie löschen desselben.
DE3789887D1 (de) Verfahren und Apparat zur Prüfung von Gesamtblut.
DE68917433D1 (de) Verfahren zur behandlung von asbest sowie asbestbehandlungsmittel.
DE3873094T2 (de) Verfahren zur aufbereitung von gas.
DE3668473D1 (de) Verfahren zur behandlung von oberflaechen und apparatur dafuer.
DE3668172D1 (de) Verfahren zur behandlung von aktiviertem siliciumpulver.
DE3670145D1 (de) Verfahren zur behandlung von abfall.
DE3775426D1 (de) Verfahren zur behandlung von gasoelen.
DE68903208D1 (de) Verfahren zur thermischen behandlung von laktoferrin.
DE3886755D1 (de) Verfahren zur behandlung von gefässkrankheiten.
DE3873846D1 (de) Behandlungsapparat und verfahren.
DE3781279T2 (de) Verfahren zur behandlung von blut.
DE69006509T2 (de) Verfahren zur behandlung von häuten.
DE3777022D1 (de) Verfahren und praeparat zur inaktivierung von viren.
DE68907914T2 (de) Verfahren zur behandlung von brandwunden.
DE3680172D1 (de) Verfahren zur behandlung von protistezellen.
DE68912463D1 (de) Konditionierte insektizide mischungen und verfahren zur insektiziden behandlung.
DE69011065D1 (de) Verfahren zur Behandlung von Nickel-Magnesium-Silikaterzen.
DE3763878D1 (de) Verfahren zur trennung von l-leucin und l-isoleucin.
DE3873486D1 (de) Verfahren und mittel zur verbindung von bauteilen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition